{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-022732","form_type":"8-K","ticker":"ELTP","cik":"0001053369","company_name":"ELITE PHARMACEUTICALS INC /NV/","filed_at":"2024-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.060349+00:00","generated_at":"2026-06-01T06:10:01.027893+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Elite Pharmaceuticals replaces auditor: Mazars USA succeeded by Forvis Mazars, LLP after Mazars USA merger","bullets":["Mazars USA resigned as auditor effective June 1, 2024, as substantially all partners/employees joined Forvis, LLP (renamed Forvis Mazars, LLP).","Forvis Mazars appointed as new independent registered public accounting firm, effective same date, approved by Audit Committee and Board.","No disagreements or reportable events between company and Mazars USA during past two fiscal years and interim period.","No prior consultations with Forvis Mazars regarding accounting principles or audit opinions before appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-022732","json":"https://secwatch.observer/filing/0001493152-24-022732.json","markdown":"https://secwatch.observer/filing/0001493152-24-022732.md","text":"https://secwatch.observer/filing/0001493152-24-022732.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1053369/000149315224022732/0001493152-24-022732-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1053369/000149315224022732/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:10:01.027893+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}